Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | GSK3A | P49840 | 1/20 | 0.32 |
| ▸ | CDK9 | P50750 | 1/20 | 0.32 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.32 |
| ▸ | TAOK1 | Q7L7X3 | 1/20 | 0.32 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.32 |
| ▸ | HTR2B | P41595 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | TOP2A | P11388 | 1/20 | 0.30 |
| ▸ | TOP2B | Q02880 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21398154 | 0.78 | GABRG2 (0.37) | IDO1GSK3ACDK9CDK5TAOK1 | |
| SCHEMBL17867644 | 0.77 | CYP3A4 (0.39) | CLK4 | |
| SCHEMBL17867643 | 0.76 | NCOA1 (0.40) | PDK2CLK4 | |
| SCHEMBL29403081 | 0.75 | PDK2 (0.44) | PDK2HTR2BSIGMAR1CA1CA2 | |
| SCHEMBL29587737 | 0.75 | PDK2 (0.44) | PDK2HTR2BSIGMAR1CA1CA2 | |
| SCHEMBL204806 | 0.75 | PDK2 (0.44) | PDK2HTR2BSIGMAR1CA1CA2 | |
| SCHEMBL17886474 | 0.74 | CYP1A2 (0.33) | CLK4 | |
| SCHEMBL29294792 | 0.72 | PDK2 (0.42) | PDK2HTR2BSIGMAR1CA1CA2 | |
| SCHEMBL29458875 | 0.72 | PDK2 (0.42) | PDK2HTR2BSIGMAR1CA1CA2 | |
| SCHEMBL5013191 | 0.72 | PDK2 (0.42) | PDK2HTR2BSIGMAR1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3040395-B1 | ORGANIC MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | LUMINESCENCE TECH CORP (TW) | 2017-10-18 | — | — | EP | disclosed |
| EP-3040395-B1 | ORGANIC MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | LUMINESCENCE TECH CORP (TW) | 2017-10-18 | — | — | EP | disclosed |
| US-9793493-B2 | Organic material and organic electroluminescent device using the same | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2017-10-17 | — | — | US | disclosed |
| US-9793493-B2 | Organic material and organic electroluminescent device using the same | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2017-10-17 | — | — | US | disclosed |
| US-9793493-B2 | Organic material and organic electroluminescent device using the same | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2017-10-17 | — | — | US | disclosed |
| EP-3040395-A1 | ORGANIC MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | Luminescence Technology Corp. (TW) | 2016-07-06 | — | — | EP | disclosed |
| EP-3040395-A1 | ORGANIC MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | Luminescence Technology Corp. (TW) | 2016-07-06 | — | — | EP | disclosed |
| US-20160190472-A1 | ORGANIC MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORP. | 2016-06-30 | — | — | US | disclosed |
| US-20160190472-A1 | ORGANIC MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORP. | 2016-06-30 | — | — | US | disclosed |
| US-20160190472-A1 | ORGANIC MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORP. | 2016-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160190472-A1 | ORGANIC MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | EBPL, OXA1L, HBS1L | PDK2 1382/4885IDO1 4288/4885GSK3A 1758/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.